Jpmorgan Chase & CO Guardant Health, Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GH
# of Institutions
331Shares Held
113MCall Options Held
680KPut Options Held
1.67M-
Vanguard Group Inc Valley Forge, PA11.6MShares$275 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$265 Million0.01% of portfolio
-
Baillie Gifford & CO5.87MShares$139 Million0.1% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.5MShares$106 Million4.27% of portfolio
-
Capital International Investors Los Angeles, CA4.47MShares$105 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.41B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...